샘플 요청 목록

 카트 문의
시장보고서
상품코드
1571948

생체 보철 시장

Bioprosthetics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 92 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생체 보철 시장은 2030년까지 119억 달러에 달할 전망입니다.

2023년에 63억 달러로 추정된 생체 보철 시장은 2030년에는 119억 달러에 이르고, 예측 기간 동안 복합 연간 성장률(CAGR)은 9.5%로 성장할 것으로 예측됩니다. 이 보고서에서 분석 한 부문 중 하나 인 이종 이식 생체 보철은 복합 연간 성장률(CAGR) 10.0%로 성장을 지속하고, 분석 기간이 끝날 때까지 83억 달러에 달할 것으로 예측됩니다. 동종 이식 생체 보철 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 8.4%로 추정됩니다.

미국 시장은 16억 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 14.1%로 성장할 것으로 예측됩니다.

미국의 생체 보철 시장은 2023년에 16억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 31억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR)은 14.1%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 4.9%와 8.5%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 5.9%로 성장할 것으로 예측됩니다.

세계 생체 보철 시장 - 주요 동향과 촉진요인 요약

생체 보철은 어떻게 농업에 혁명을 일으키는가?

생체 보철은 기존의 화학 농약을 대체하는 지속 가능하고 환경 친화적 인 농약으로서 현대 농업의 게임 체인저로 부상하고 있습니다. 미생물, 식물 추출물 및 기타 유기 화합물과 같은 천연 또는 생물학적 기원으로부터 유래된 이러한 농약은 보다 특이적이고 환경친화적인 방식으로 해충을 표적으로 합니다. 생체 보철은 해충, 질병 및 잡초를 효과적으로 제거하면서 환경에 대한 악영향을 최소화하도록 설계되었습니다. 인간과 익충, 야생 생물 등 비표적 생물에 대한 독성이 낮기 때문에 인기가 높아지고 있습니다. 지속가능한 농업에 대한 세계의 주목이 높아지고 유기농산물에 대한 수요가 높아지는 가운데, 생체 보철은 종합적 병해충 관리(IPM) 프로그램에 필수적인 요소가 되고 있습니다. 이러한 제품은 농작물을 보호할 뿐만 아니라 생물 다양성과 토양의 건전성을 지원하기 때문에 생산성과 생태계 책임의 양립을 목표로 하는 농가에게 중요한 도구가 되고 있습니다. 농업 산업이 화학농약의 사용을 줄이려는 규제 압력 증가에 직면하면서, 생체 보철은 작물의 수율과 환경을 모두 보호하기 위한 실행 가능한 솔루션을 제공합니다.

최종 용도는 어떻게 생체 보철의 채용을 형성하는가?

생체 보철의 용도는 다양한 농업 분야에서 급속히 확대되고 있으며, 그 중에서도 과일, 야채, 특수작물이 수요의 주요 견인역이 되고 있습니다. 이러한 작물은 병해충에 매우 민감한 경우가 많으며, 정밀농업 전략의 일환으로 적용되는 생체 보철의 표적을 좁힌 작용으로부터 큰 혜택을 받고 있습니다. 예를 들어 유기농가와 지속가능한 농가는 유기인증을 손상시키지 않고 병해충을 관리하기 위해 생체 보철 살충제, 살균제, 제초제의 채용을 늘리고 있습니다. 원예 분야에서는 관엽 식물과 잔디를 보호하기 위해 생물 처리 제품이 널리 사용되며 공공 공간, 공원 및 골프 코스를 통해 안전한 대안을 제공합니다. 또한, 이러한 농약은 모기 및 기타 질병을 매개하는 곤충을 제거하는 것이 중요한 공중 보건에서 매개 질병을 관리하는 데에도 도움이 됩니다. 농작물뿐만 아니라 생체 보철은 온실 재배에도 응용됩니다. 온실 재배에서는 환경이 통제되기 때문에 해충 방제와 식물 건강의 균형을 유지하는 것이 매우 중요합니다. 다양한 분야에서 생체 보철의 사용이 확대되고 있는 것은 현대농업에 있어서의 생체 보철의 다용도성과 중요성의 높아짐을 부각시키고 있습니다.

생체 보철의 진보에 있어서 기술이 완수하는 역할이란?

기술의 진보는 생체 보철의 효능과 적용을 강화하고 농민들에게 더 안정적이고 사용하기 쉽도록 만드는 데 중요한 역할을합니다. 첨단 발효, 제제 기술의 개발에 의해 미생물 기반의 생체 보철의 안정성, 보존성, 효력이 개선되어, 농업에의 폭넓은 도입이 가능하게 되었습니다. 게다가 드론이나 센서 기술 등의 정밀 농업에 있어서의 기술 혁신에 의해 생체 보철의 보다 적정한 살포가 가능하게 되어, 낭비가 줄어들어, 필요한 장소에만 치료가 실시되게 되어 있습니다. 이 정밀도는 해충 방제의 효율을 향상시킬 뿐만 아니라 농약 사용으로 인한 전체 환경 실적를 줄일 수 있습니다. 게다가, 생명공학의 진보로 유익한 생물에 안전하면서도 저항성 해충에 대해 보다 효과적인 유전자 변형 생체 보철이 개발되고 있습니다. 이러한 혁신은 AI를 활용한 예측 모델과 함께 보다 우수한 해충 모니터링과 농약 살포의 정확한 타이밍을 가능하게 하여 그 효과를 극대화합니다. 또한 디지털 농업 툴과 생체 보철 살포의 통합이 진행됨에 따라 농가는 보다 지속 가능한 해충 관리 방법을 채용할 수 있어 데이터 주도형 농업을 향한 세계의 동향과 일치하고 있습니다.

생체 보철 시장의 성장을 가속하는 요인은 무엇인가?

생체 보철 시장의 성장은 지속 가능한 농법에 대한 수요 증가, 화학 농약 사용에 대한 엄격한 규제, 유기 식품 및 잔류 농약이없는 식품으로 소비자의 선호 변화 등 여러 요인으로 인해 발생합니다. 주요 촉진요인 중 하나는 합성 화학 농약과 관련된 환경 및 건강 위험에 대한 인식이 높아져 소비자와 정부 모두가보다 안전한 대체 농약을 요구하게 된 것입니다. 주요 농업 경제국의 규제 기관은 기존의 농약 사용에 대한 규제를 강화하고 있으며, 그 결과 생체 보철 제품의 채용이 증가하고 있습니다. 게다가 유기농과 지속가능한 방법으로 재배된 식품에 대한 소비자 수요가 증가하고 있는 것도 농가들이 해충 관리 전략의 일환으로 생체 보철을 도입하는 것을 뒷받침하고 있습니다. 또 다른 요인은 화학 농약에 대한 해충 저항성의 확산이 확대됨에 따라 새로운 작용 모드를 가진 생물화 솔루션이 보다 매력적인 선택이 되고 있습니다. 생명공학과 제제기술의 혁신은 또한 이러한 제품의 효율성과 보존성을 향상시켜 시장 성장에 기여하고 있습니다. 게다가 관행농법과 유기농법 모두에서 종합적 해충관리(IPM) 프로그램의 확대는 IPM이 강조하는 지속가능하고 적정한 접근법을 보완하는 것으로 생체 보철 수요를 끌어올리고 있습니다. 농업 부문이 지속가능성과 생산성을 우선시하는 가운데 생체 보철 시장은 꾸준히 성장할 것으로 예상됩니다.

조사 대상 기업 예(주목의 36사)

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.10.24

Global Bioprosthetics Market to Reach US$11.9 Billion by 2030

The global market for Bioprosthetics estimated at US$6.3 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Xenograft Bioprosthetics, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in the Allograft Bioprosthetics segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 14.1% CAGR

The Bioprosthetics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Biorational Pesticides Market – Key Trends & Drivers Summarized

How Are Biorational Pesticides Revolutionizing Agriculture?

Biorational pesticides are emerging as a game-changer in modern agriculture, offering a sustainable and environmentally friendly alternative to traditional chemical pesticides. These pesticides, derived from natural or biological origins such as microorganisms, plant extracts, or other organic compounds, target pests in a more specific and eco-friendly manner. Biorational pesticides are designed to minimize negative environmental impacts while effectively controlling pests, diseases, and weeds. They are gaining popularity due to their reduced toxicity to non-target organisms, including humans, beneficial insects, and wildlife. With the increasing global focus on sustainable agriculture and the growing demand for organic produce, biorational pesticides are becoming an integral part of Integrated Pest Management (IPM) programs. These products not only help protect crops but also support biodiversity and soil health, making them a critical tool for farmers seeking to balance productivity with ecological responsibility. As the agricultural industry faces increasing regulatory pressures to reduce chemical pesticide use, biorational pesticides offer a viable solution to safeguard both crop yields and the environment.

How Are End-Use Applications Shaping the Adoption of Biorational Pesticides?

The application of biorational pesticides is expanding rapidly across various agricultural sectors, with fruits, vegetables, and specialty crops being key drivers of demand. These crops, which are often highly sensitive to pests and diseases, benefit significantly from the targeted action of biorational pesticides, which are applied as part of precision agriculture strategies. For example, organic and sustainable farmers are increasingly adopting biorational insecticides, fungicides, and herbicides to manage pests and diseases without compromising their organic certification. In horticulture, biorational products are widely used to protect ornamentals and turf, offering a safer alternative for public spaces, parks, and golf courses. Additionally, these pesticides are gaining traction in the management of vector-borne diseases in public health, where controlling mosquitoes and other disease-carrying insects is critical. Beyond field crops, biorational pesticides are finding applications in greenhouse cultivation, where maintaining a balance between pest control and plant health is crucial due to the controlled environment. The expanding use of biorational pesticides across diverse sectors highlights their versatility and growing importance in modern agriculture.

What Role Does Technology Play in Advancing Biorational Pesticides?

Technological advancements are playing a crucial role in enhancing the effectiveness and application of biorational pesticides, making them more reliable and accessible for farmers. The development of advanced fermentation and formulation technologies has improved the stability, shelf-life, and potency of microbial-based biorational products, enabling their broader adoption in agriculture. Additionally, innovations in precision agriculture, such as drones and sensor technologies, are enabling more targeted application of biorational pesticides, reducing wastage and ensuring that the treatments are applied only where needed. This precision not only enhances pest control efficiency but also reduces the overall environmental footprint of pesticide usage. Furthermore, advancements in biotechnology have led to the creation of genetically engineered biopesticides that are more effective against resistant pests while remaining safe for beneficial organisms. These innovations, along with AI-driven predictive models, allow for better pest monitoring and more accurate timing of pesticide applications, maximizing their efficacy. The growing integration of digital farming tools with biorational pesticide application is also helping farmers adopt more sustainable pest management practices, aligning with global trends toward data-driven agriculture.

What Factors Are Driving Growth in the Biorational Pesticides Market?

The growth in the biorational pesticides market is driven by several factors, including increased demand for sustainable farming practices, stringent regulations on chemical pesticide use, and shifting consumer preferences towards organic and residue-free food. One of the key drivers is the growing awareness of the environmental and health risks associated with synthetic chemical pesticides, prompting both consumers and governments to seek safer alternatives. Regulatory bodies in major agricultural economies are tightening restrictions on the use of traditional pesticides, leading to increased adoption of biorational products. Furthermore, the rising consumer demand for organic and sustainably grown food is pushing farmers to embrace biorational pesticides as part of their pest management strategy. Another factor is the increasing prevalence of pest resistance to chemical pesticides, which has made biorational solutions, with their novel modes of action, a more attractive option. Technological innovations in biotechnology and formulation techniques are also contributing to market growth by improving the efficacy and shelf-life of these products. Additionally, the expansion of Integrated Pest Management (IPM) programs in both conventional and organic farming is driving the demand for biorational pesticides, as they complement the sustainable and targeted approach that IPM emphasizes. As the agricultural sector continues to prioritize sustainability and productivity, the market for biorational pesticides is expected to grow steadily.

Select Competitors (Total 36 Featured) -

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bioprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Propels Demand for Bioprosthetic Heart Valves
    • Technological Advancements in Tissue Engineering Drive Innovation in Next-Generation Bioprosthetics
    • Growing Preference for Minimally Invasive Surgeries Spurs Adoption of Bioprosthetic Implants
    • Increasing Use of Bioprosthetic Materials in Orthopedic Applications Expands the Addressable Market
    • Improved Biocompatibility and Longevity of Bioprosthetics Strengthens Their Adoption in Cardiovascular and Orthopedic Surgeries
    • Growing Focus on Customized Bioprosthetic Solutions for Personalized Medicine Creates New Market Opportunities
    • Rising Demand for Aesthetic and Functional Bioprosthetics in Reconstructive Surgeries Drives Market Growth
    • Advances in Xenotransplantation Technologies Expand the Development and Adoption of Bioprosthetic Devices
    • Increasing R&D in Biomaterials and Biopolymer Technologies Propels Innovation in Bioprosthetic Design
    • Favorable Reimbursement Policies in Developed Markets Drive Adoption of Bioprosthetic Implants in Healthcare Systems
    • Growing Role of 3D Printing in Manufacturing Custom Bioprosthetics Expands Opportunities for Personalized Implants
    • Increasing Incidence of Sports Injuries and Trauma Surgeries Generates Demand for Bioprosthetic Ligaments and Tendons
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Xenograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Allograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Plastic Surgery & Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Bioprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • JAPAN
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CHINA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • EUROPE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • FRANCE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • GERMANY
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • INDIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AFRICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제